Hostname: page-component-84c44f86f4-7ttm6 Total loading time: 0 Render date: 2025-10-14T15:38:10.001Z Has data issue: false hasContentIssue false

Healthcare-associated respiratory viral infections are an important cause of mortality and morbidity– evidence from cohort study of 1700 patients

Part of: APSIC 2024

Published online by Cambridge University Press:  03 September 2025

Zongxin Dai
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases
Paul Anantharajah Tambyah
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases National University of Singapore, Yong Loo Lin School of Medicine
Somani Jyoti
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases National University of Singapore, Yong Loo Lin School of Medicine
Hwang Ching Chan
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases
Revathi Sridhar
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases
Vennila Gopal
Affiliation:
National University of Singapore, Yong Loo Lin School of Medicine
Sean Wu
Affiliation:
National University Hospital, Singapore, Department of Medicine, Division of Infectious Diseases

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objectives: Healthcare-associated respiratory viral infections (HA-RVI) remain a threat despite the fading memory of the pandemic. To better understand the impact of HA-RVI, we reviewed endemic respiratory viral infections in our tertiary academic hospital just before the pandemic. Methods: A retrospective analysis of a hospital epidemiology database with all patients tested positive for respiratory viruses between Jan2016 – Dec2019 was conducted. Testing was ordered by attending physicians and done using immunofluorescence assays or multiplex PCR. HA-RVI patients were identified based on positive virologic tests >48 hours after admission. Data analyses were performed on Vassar Stats. Results: Of the 1700 patients included in this study, 315(18.5%) had HA-RVI while 1385(81.5%) had community-acquired infections (CAI). Influenza, enterovirus/rhinoviruses and respiratory syncytial virus were the most common viruses. Compared with CAI, HA-RVI patients were older (mean age 37.129.7 vs 21.427.5 years, p<0.001), had recent hospitalisations (OR 1.5, 95% CI:1.1-2.1, p=0.007), underlying bronchial asthma or COPD (OR 2.8, 95% CI:1.5-5.3, p=0.002) and were immunosuppressed (OR 7.6, 95% CI:4.3-13.4, p<0.001). Interestingly, HA-RVI patients were less likely to have fever (49.8% vs 66.4%, p<0.001), cough (42.2% vs 67.3%, p<0.001) or shortness of breath (17.5% vs 26.6%, p=0.02). Despite fewer symptoms, HA-RVI patients were more likely to have pneumonia with abnormal chest x-rays (33.3% vs 22.7%, RR 1.14, 95% CI:1.02-1.29, p=0.04), longer lengths of stay (mean 21.236.7 vs 514 days, p<0.001), higher rates of ICU admission (14.9% vs 8.1%, OR 2.0, 95% CI:1.4-2.9, p<0.001), and mortality (4.8% vs 0.6%, OR 8.6, 95% CI:3.6-20.5, p<0.001). Conclusions: Patients who are older, have pre-existing respiratory disorders or are immunosuppressed face greater HA-RVI risk. HA-RVI patients are less likely to exhibit typical respiratory infection symptoms, potentially delaying diagnosis. This probably contributes to increased morbidity and mortality associated with HA-RVI which underscore the importance of hospital infection prevention even for endemic respiratory viruses.

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America